Twist Bioscience Corp (NAS:TWST)
$ 46.39 -0.69 (-1.47%) Market Cap: 2.72 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 85/100

Twist Bioscience Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / 05:40PM GMT
Release Date Price: $27.46 (+4.81%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Hi, everybody. Welcome. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of hosting Twist Biosciences this morning, Emily Leproust, Chief Executive Officer and Co-Founder; and Jim Thorburn, Chief Financial Officer. Emily, Jim, thank you for joining.

James M. Thorburn
Twist Bioscience Corporation - CFO

Thank you.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman, President & CEO

Thank you.

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Why don't I kind of let you set the stage firstly and then talk a little bit about some of the key accomplishments over the past 6 to 12 months and your most recent results and maybe some key opportunities and goals that investors should be focused on for the balance of the year now that we're sitting at midyear?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot